ADVERTISEMENT

Andrew Zhu

O-021: Ramucirumab in Advanced Hepatocellular Carcinoma and Elevated Alpha-fetoprotein Following Sorafenib: Outcomes by Prior Transarterial Chemoembolisation From Two Randomised, Double-blind, Placebo-controlled Phase 3 Studies (REACH-2 and REACH)

Access the abstract

Yoon-Koo Kang , MD, PhD;

Peter R. Galle , MD, PhD;

Giovanni Brandi ;

Kenta Motomura ;

Takuji Okusaka ;

Masafumi Ikeda ;

Richard A. Hubner ;

Chunxiao Wang ;

Masatoshi Kudo , MD, PhD;

William Schelman ;

Richard S. Finn ;

07/31/2019

O-008: A Phase 2 study of Ipilimumab and Nivolumab with Radiation in MSS metastatic colorectal adenocarcinoma and metastatic pancreatic ductal adenocarcinoma

Access the abstract

Aparna R. Parikh ;

Jeffrey Clark ;

Lawrence S. Blaszkowsky ;

David P. Ryan ;

Bruce Giantonio ;

Emily E. Van Seventer ;

Lorraine Drapek , DNP, FNP-BC;

Lauren Matlack ;

Bronwen Foreman ;

David T. Ting ;

Ryan B. Corcoran ;

Theodore S. Hong ;

07/31/2019

Pembrolizumab (Pembro) therapy vs best supportive care (BSC) in advanced hepatocellular carcinoma (HCC): KEYNOTE-240

BackgroundPembro received accelerated approval for second-line therapy in pts with advanced HCC, based on the phase 2, KEYNOTE-224 trial. KEYNOTE-240 was a randomized, phase 3 study of P...

Marcelo Garrido ;

Stephen Lam Chan , MD;

Jennifer J. Knox ;

Bruno Daniele ;

Scot Ebbinghaus ;

Abby B. Siegel ;

Julien Edeline ;

Baek-Yeol Ryoo ;

Ann-Lii Cheng , MD, PhD;

Philippe Merle ;

Masatoshi Kudo , MD, PhD;

Mohamed Bouattour ;

Richard S. Finn ;

Valeriy Vladimirovich Breder , MD, PhD;

Sadahisa Ogasawara ;

07/01/2019

CIO 2022-33 Atezolizumab + Bevacizumab vs Sorafenib in HCC Patients With Prior Locoregional Therapy: IMbrave150 Exploratory Data

BEST POSTER WINNER Late-breaking abstract / Here, we report post hoc exploratory results of atezo + bev vs sorafenib (sor) in pts who had prior LRT using updated IMbrave150 data with 12 m...

Michel P. Ducreux , MD, PhD;

Sairy Hernandez ;

Amit G. Singal ;

Allan Nicholas , MD, FACC;

Riad Salem , MD, MBA;

Richard S. Finn ;

Peter R. Galle , MD, PhD;

Philippe Merle ;

10/17/2022

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

November 6 ⁠–⁠ November 8

NEI Congress

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

WoundCon

November 8

Dermatology Week

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Advertisement

Advertisement